Robert Andrew Goodlad

Robert Andrew Goodlad

Auto-generated profile, based on publicly available information

Robert Andrew Goodlad

Histopathology Unit, Cancer Research UK, London Research Institute, London, UK

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Annals of Surgery
Verified
Journal Article
Closed access
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
CBCynthia Borg
Cynthia Borg
KWKatharina Wallis
Katharina Wallis
RVRoyce Vincent
Royce Vincent
MBMarco Bueter
Marco Bueter
SASimon J. B. Aylwin
Simon J. B. Aylwin
We aimed to determine changes in crypt cell proliferation and glucagon-like peptide-2 (GLP-2) in rodents and man after Roux-en-Y gastric bypass (RYGB). Roux-en-Y gastric bypass results in sustained weight loss and reduced appetite with only mild gastrointestinal side effects. Glucagon-like peptide-2 released from intestinal l-cells after nutrient intake stimulates intestinal crypt cell proliferation and mitigates the effects of gut injury. Wistar rats underwent either RYGB (n = 6) or sham procedure (n = 6) and plasma GLP-2, GLP-1, and gut hormone peptide YY (PYY) were measured after 23 days. Biopsies from the terminal ileum were stained using the antibody to Ki67, which detects cyclins and hence demonstrates cells in the S-phase of the cell cycle. The total number of cells, number of mitosis, and number of labeled cells per crypt were counted. Obese patients (n = 6) undergoing RYGB were evaluated following a 420 kcal meal preoperatively, and 1, 3, 6, 12, and 24 months later for responses in l-cell products such as GLP-2, GLP-1, total PYY, and PYY3–36. Rat GLP-2 levels after RYGB were elevated 91% above sham animals (P = 0.02). At necropsy, mitotic rate (P < 0.001) and cells positive for the antibody Ki67 (P < 0.001) were increased, indicating crypt cell proliferation. Human GLP-2 after RYGB reached a peak at 6 months of 168% (P < 0.01) above preoperative values. Area under the curve for GLP-1 (P < 0.0001), total PYY (P < 0.01), and PYY3–36 (P < 0.05) responses increased progressively over 24 months. RYGB leads to increased GLP-2 and mucosal crypt cell proliferation. Other gut hormones from l-cells remain elevated for at least 2 years in humans. These findings may account for the restoration of the absorptive surface area of the gut, which limits malabsorption and contributes to the long-term weight loss after RYGB.

1 October 1990 in The Lancet
Verified
Journal Article
Closed access
SLS Levi
S Levi
MWM.J Walport
M.J Walport
HHH.J.F Hodgson
H.J.F Hodgson
RGR.A Goodlad
R.A Goodlad
CLC.Y Lee
C.Y Lee
NWN.A Wright
N.A Wright

5 March 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RPRaymond John Playford
Raymond John Playford
TMT Marchbank
T Marchbank
RGR A Goodlad
R A Goodlad
RCR A Chinery
R A Chinery
RPR Poulsom
R Poulsom
AHA M Hanby
A M Hanby
PS2 is a member of the trefoil peptide family, all of which are overexpressed at sites of gastrointestinal injury. We hypothesized that they are important in stimulating mucosal repair. To test this idea, we have produced a transgenic mice strain that expresses human pS2 (hpS2) specifically within the jejunum and examined the effect of this overexpression on proliferation and susceptibility to indomethacin-induced damage. A transgenic mouse was produced by microinjecting fertilized oocytes with a 1.7-kb construct consisting of rat intestinal fatty acid binding protein promoter (positions -1178 to +28) linked to full-length (490 bp) hpS2 cDNA. Screening for positive animals was by Southern blot analysis. Distribution of hpS2 expression was determined by using Northern and Western blot analyses and immunohistochemical staining. Proliferation of the intestinal mucosa was determined by assessing the crypt cell production rate. Differences in susceptibility to intestinal damage were analyzed in animals that had received indomethacin (85 mg/kg s.c.) 0-30 h previously. Expression of hpS2 was limited to the enterocytes of the villi within the jejunum. In the nondamaged intestine, villus height and crypt cell production rate were similar in transgenic and negative (control) litter mates. However, there was a marked difference in the amount of damage caused by indomethacin in control and transgenic animals in the jejunum (30% reduction in villus height in controls vs. 12% reduction in transgenic animals, P < 0.01) but the damage sustained in the non-hpS2-expressing ileal region was similar in control and transgenic animals. These studies support the hypothesis that trefoil peptides are important in stimulating gastrointestinal repair.

1 July 1998 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
HWHarpreet S. Wasan
Harpreet S. Wasan
HPHyun-Sook Park
Hyun-Sook Park
KLKen C. Liu
Ken C. Liu
NMNirmala K. Mandir
Nirmala K. Mandir
AWAngela Winnett
Angela Winnett
NWNicholas A. Wright
Nicholas A. Wright

1 February 2002 in Gut
Verified
Journal Article
Open access
PDF file
WWW-M Wong
W-M Wong
NMN Mandir
N Mandir
RGR A Goodlad
R A Goodlad
BWB C Y Wong
B C Y Wong
SGS B Garcia
S B Garcia
NWN A Wright
N A Wright
Background: The histogenesis of human colorectal hyperplastic polyps and colorectal adenomas is poorly understood even now. Method: Human colorectal adenomas, hyperplastic polyps, and normal colorectal mucosae (patients with familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma were excluded) were obtained during colonoscopy and microdissected into individual crypts. Morphology, cell proliferation characteristics, and fission indices of crypts isolated from these lesions were then studied. Results: Crypts isolated from colorectal adenomas and colorectal hyperplastic polyps were significantly larger (p<0.001) than crypts from normal colorectal mucosae. Crypt fission was an uncommon event in normal colonic mucosae but common in crypts isolated from adenomas and hyperplastic polyps (p<0.001). Analysis of the distribution of mitoses suggested an upward expansion of the proliferation compartment in adenomas to the surface of the crypt with no reversal of proliferating cell distribution, as has previously been described. Conclusions: Sporadic human colorectal adenomas and hyperplastic polyps grow by the process of crypt fission. Expansion of the proliferative compartment was demonstrated in crypts from adenomas, consistent with deregulation of cell cycle control.

1 May 1987 in Gut
Verified
Journal Article
Open access
PDF file
RGR A Goodlad
R A Goodlad
TWT J Wilson
T J Wilson
WLW Lenton
W Lenton
HGH Gregory
H Gregory
KMK G McCullagh
K G McCullagh
NWN A Wright
N A Wright
The effects of beta-urogastrone/human epidermal growth factor (URO-EGF) on intestinal epithelial cell proliferation were studied in rats in which intestinal cell proliferation had been reduced to a steady state basal level, by maintaining the rats on total parenteral nutrition. The accumulation of arrested metaphases over a two hour time period was determined in a dose response study. Increasing doses of URO-EGF progressively raised the two hour collection of metaphases and intestinal weights. Intravenous infusion of URO-EGF was also effective in restoring cell proliferation when it was infused after the intestine had become hypoproliferative. beta-urogastrone/human epidermal growth factor administered through an intragastric cannulae thrice daily had no significant effect on intestinal weight or crypt cell production rate or metaphase collection. It is proposed that one of the in vivo actions of urogastrone-epidermal growth factor is the maintenance of gastrointestinal growth and that this occurs through a systemic rather than a luminal mechanism.